{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Auraptene", "Chemoprevention", "Degenerative diseases", "Hypertension", "Lipid profile"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27771936", "DateCompleted": {"Year": "2017", "Month": "07", "Day": "10"}, "DateRevised": {"Year": "2017", "Month": "11", "Day": "16"}, "Article": {"ArticleDate": [], "ELocationID": [], "Language": ["eng"], "Journal": {"ISSN": "0065-2598", "JournalIssue": {"Volume": "929", "PubDate": {"Year": "2016"}}, "Title": "Advances in experimental medicine and biology", "ISOAbbreviation": "Adv Exp Med Biol"}, "ArticleTitle": "Auraptene and Its Role in Chronic Diseases.", "Pagination": {"StartPage": "399", "EndPage": "407", "MedlinePgn": "399-407"}, "Abstract": {"AbstractText": ["Auraptene (7-geranyloxycoumarin) is the best known and most abundant prenyloxycoumarin present in nature. It is synthesized by various plant species, mainly those of the Rutaceae and Umbeliferae (Apiaceae) families, comprising many edible fruits and vegetables such as lemons, grapefruit and orange. Auraptene has shown a remarkable effect in the prevention of degenerative diseases, in particular it has been reported to be one the most promising known natural chemopreventive agents against several types of cancer. The aim of this chapter is to review the effects of auraptene in the prevention and treatment of different chronic diseases."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine and Therapeutics, University of Pavia, Fondazione IRCCS Policlinico San Matteo, P.le C. Golgi, 2-27100, Pavia, Italy. giuseppe.derosa@unipv.it."}, {"Identifier": [], "Affiliation": "Center for Prevention, Surveillance, Diagnosis and Treatment of Rare Diseases, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. giuseppe.derosa@unipv.it."}, {"Identifier": [], "Affiliation": "Center for the Study of Endocrine-Metabolic Pathophysiology and Clinical Research, University of Pavia, Pavia, Italy. giuseppe.derosa@unipv.it."}, {"Identifier": [], "Affiliation": "Laboratory of Molecular Medicine, University of Pavia, Pavia, Italy. giuseppe.derosa@unipv.it."}], "LastName": "Derosa", "ForeName": "Giuseppe", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine and Therapeutics, University of Pavia, Fondazione IRCCS Policlinico San Matteo, P.le C. Golgi, 2-27100, Pavia, Italy."}, {"Identifier": [], "Affiliation": "Center for Prevention, Surveillance, Diagnosis and Treatment of Rare Diseases, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy."}, {"Identifier": [], "Affiliation": "PhD School in Experimental Medicine, University of Pavia, Pavia, Italy."}], "LastName": "Maffioli", "ForeName": "Pamela", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. sahebkara@mums.ac.ir."}, {"Identifier": [], "Affiliation": "School of Medicine and Pharmacology, Metabolic Research Centre, Royal Perth Hospital, University of Western Australia, Perth, Australia. sahebkara@mums.ac.ir."}, {"Identifier": [], "Affiliation": "Department of Medical Biotechnology, School of Medicine, Mashhad University of Medical Sciences, P.O. Box: 91779-48564, Mashhad, Iran. sahebkara@mums.ac.ir."}], "LastName": "Sahebkar", "ForeName": "Amirhossein", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Adv Exp Med Biol", "NlmUniqueID": "0121103", "ISSNLinking": "0065-2598"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antihypertensive Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Coumarins"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypolipidemic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "F79I1ZEL2E", "NameOfSubstance": "aurapten"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Antihypertensive Agents"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Chronic Disease"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Coumarins"}, {"QualifierName": ["methods"], "DescriptorName": "Drug Discovery"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Hypolipidemic Agents"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2016", "Month": "10", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "7", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "10", "Day": "25", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27771936", "10.1007/978-3-319-41342-6_19"]}}], "PubmedBookArticle": []}